Closed Suction Drain or Not After Total Hip Arthroplasty

January 17, 2019 updated by: Yasser E khalifa, Assiut University

Closed Suction Drain or Not After Total Hip Arthroplasty: A Randomized Controlled Trial

Comparative randomised study to clarify which better to use or no use of closed suction drain system after total hip arthroplasty regarding amount of blood loss, need for blood transfusion, risk for superficial infection, ecchymosis, wound discharge, effect on early post-operative rehabilitation. Patients will be followed up for one month postoperative clinically (Harris Hip score system), laboratory (Hb level), and radiologically (A-P view plain x-ray of the hip).

Study Overview

Detailed Description

Total Hip Arthroplasty (THA) wounds are prone to formation of hematomas. Hematomas may increase the incision tension, leading to wound discharge and providing a good medium for bacteria, increase post-operative pain, limitation of range of motion of hip joint and prolong post-operative rehabilitation duration, also may cause ecchymosis, and tension vesicles around the surgical wound.

So use of closed suction drain system may reduce these complications. Nevertheless some recent studies have claimed that drainage can cause other complications and does not reduce hematoma formation and risk for infection. Furthermore, some studies have shown that drainage increase blood loss after THA which may both lead to increase blood transfusion requirements and provide an entry point for skin microorganisms.

Some other studies have found that no significance between use and non use of suction drain after THA.

So the investigators will take this issue for study a comparison between benefits and hazards of use and non use of suction drain after THA.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt, 71111
        • Faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary total hip arthroplasty (THA)

Exclusion Criteria:

  • Revision cases
  • Uncontrolled bleeding tendency (prothrombin conc. Less than 70%)
  • History of deep venous thrombosis
  • Sever liver impairment (liver failure)
  • Sever renal impairment (S. creatinine more than 3)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: A(drain group)
patients of primary THA will have closed suction drain introduced intraoperative at surgical site
using closed suction drain system postoperative
Placebo Comparator: B(No drain group)
patients of primary THA will have the surgical wound be closed with no suction drain
the surgical wound will be closed with no suction drain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
change in Hb level
Time Frame: preoperative and 24 hrs postoperative
preoperative and 24 hrs postoperative

Secondary Outcome Measures

Outcome Measure
Time Frame
amount of blood loss
Time Frame: upto 24 hrs postoperative
upto 24 hrs postoperative
amount of blood transfusion
Time Frame: upto 24 hrs postoperative
upto 24 hrs postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Actual)

August 1, 2017

Study Completion (Actual)

January 1, 2018

Study Registration Dates

First Submitted

July 14, 2016

First Submitted That Met QC Criteria

July 23, 2016

First Posted (Estimate)

July 27, 2016

Study Record Updates

Last Update Posted (Actual)

January 22, 2019

Last Update Submitted That Met QC Criteria

January 17, 2019

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • AUHOR1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Hip Arthroplasty

Clinical Trials on closed suction drain

Subscribe